Desoxypipradrol, commonly abbreviated as 2-DPMP, is a potent stimulant compound known primarily for its long-lasting effects and strong affinity for the dopamine transporter. It is a member of the piperidine chemical class and has been investigated for its capacity to block dopamine reuptake without releasing it—making it a transporter inhibitor rather than a releaser. Though it is not approved for human or veterinary use, 2-DPMP has become a subject of interest in neurochemical and behavioral pharmacology due to its unique duration and high potency at low doses.

• Belongs to the piperidine class of compounds: Desoxypipradrol is structurally based on a piperidine ring with two phenyl groups, a configuration that contributes to its lipophilicity and high dopamine transporter binding affinity.

• Acts as a dopamine reuptake inhibitor (DRI): It blocks the dopamine transporter (DAT), leading to increased extracellular dopamine levels, without stimulating dopamine release like amphetamines.

• Highly potent even at low milligram doses: Animal models suggest that even microgram quantities can significantly impact locomotion and reward-related behavior, marking it as one of the strongest DRIs in laboratory use.

• Long duration of action: Unlike most stimulants, the effects of 2-DPMP can last 12–24 hours or more due to its resistance to metabolic breakdown.

• No therapeutic or medical approval: It is not used in any clinical context and is sold strictly as a research chemical for non-human laboratory testing.

• Has gained attention in forensic toxicology: Due to its history in the “legal high” market, some toxicological investigations use 2-DPMP as a reference compound.

• May share structural similarities with methylphenidate: Although more potent and longer-lasting, 2-DPMP shares a general mechanism of action with methylphenidate, making it useful in comparative stimulant studies.

Pharmacologically, Desoxypipradrol operates by binding tightly to the dopamine transporter and preventing the reuptake of dopamine back into presynaptic neurons. This mechanism results in elevated levels of dopamine in the synaptic cleft, which contributes to heightened stimulation, increased locomotor activity, and prolonged wakefulness. Unlike classical amphetamines, 2-DPMP does not act as a releasing agent but instead inhibits dopamine clearance without causing vesicular release.

• Selective for the dopamine transporter (DAT): Desoxypipradrol demonstrates high affinity for DAT, with minimal interaction at serotonin (SERT) or norepinephrine (NET) transporters at typical research concentrations.

• Non-releasing mechanism: Unlike amphetamines, which reverse the flow of dopamine through the transporter, 2-DPMP simply blocks reuptake, preserving normal vesicular dopamine storage.

• Prolonged action due to slow metabolism: The compound’s resistance to enzymatic degradation means it remains active in the system for extended periods, contributing to its long duration of pharmacological effect.

• Does not induce neurotransmitter release: In vitro and in vivo studies confirm that 2-DPMP increases extracellular dopamine by preventing reabsorption, not by forcing its release.

• Lipophilic nature enhances brain penetration: The compound’s structure allows it to cross the blood-brain barrier efficiently, allowing for rapid onset of central nervous system effects.

• Minimal effect on serotonin systems: 2-DPMP does not meaningfully affect serotonin levels, which reduces the risk of serotonin syndrome when studied alone.

Desoxypipradrol is notable for its exceptionally prolonged duration of action, far exceeding most stimulant compounds commonly used in research. This extended activity has made it a focus for long-term dopamine transporter inhibition studies and behavioral endurance testing in animal models. The compound’s half-life, lipophilicity, and resistance to metabolic breakdown contribute to its sustained effects.

• Active duration of 12 to 24 hours: Most research models report stimulant effects lasting between 12 and 24 hours following administration.

• Onset occurs within 1–2 hours: After dosing, behavioral effects such as increased locomotion or wakefulness typically begin within 60 to 120 minutes.

• Half-life exceeds 16 hours in many animal studies: The compound is eliminated slowly due to its structural resistance to enzymatic metabolism.

• May cause residual stimulation beyond active phase: Low-level effects have been observed for up to 36 hours post-administration in rodents, depending on dosage.

• Implications for repeated exposure: Researchers must account for its long half-life when designing experiments involving multiple sessions or cumulative dosing.

• Requires careful dose spacing: To avoid compound buildup in test subjects, appropriate washout periods should be planned between exposures.

The legal status of Desoxypipradrol varies widely depending on the country or region. While some areas have explicitly banned its possession or use due to its history as a “legal high,” others allow it under the condition that it is used strictly for research purposes and not for human consumption. RC Plug ensures compliance by shipping only to locations where 2-DPMP is permitted under chemical research exemptions.

• Banned or controlled in some countries: For example, the UK classifies 2-DPMP as a Class B controlled substance under the Misuse of Drugs Act.

• Unscheduled but restricted under analogue laws in the US: While not federally scheduled, its similarity to other stimulants may place it under the Federal Analogue Act in certain applications.

• Permitted for research in some EU countries: Depending on local chemical control legislation, institutions may legally import and handle 2-DPMP for scientific investigation.

• Always sold as ‘not for human consumption’: To comply with international standards, reputable vendors like RC Plug clearly label 2-DPMP as a research-only product.

• Researchers must confirm jurisdictional compliance: It is the responsibility of the buyer to verify local regulations prior to placing an order.

• Shipped with documentation upon request: We can provide batch-specific COAs and compliance statements to support your import documentation process.

Due to its high potency and long duration of action, Desoxypipradrol requires strict safety precautions in laboratory environments. Improper handling can lead to accidental exposure or contamination, both of which pose serious safety risks. Researchers should always follow institutional safety protocols and treat 2-DPMP with the same respect as any high-potency stimulant.

• Use protective equipment at all times: Gloves, safety goggles, and lab coats are essential when handling 2-DPMP to avoid dermal or ocular contact.

• Conduct experiments in a ventilated area: Fume hoods or controlled airflow systems are recommended to prevent inhalation of fine powder particles.

• Measure precisely using milligram or microgram scales: Doses for animal models are extremely small; even slight miscalculations can lead to overstimulation or toxicity.

• Store compound securely: Keep 2-DPMP in a cool, dry, light-protected environment, clearly labeled and inaccessible to unauthorized personnel.

• Avoid cross-contamination: Always use clean, dedicated tools for measuring or transferring the compound to prevent contamination of other substances or equipment.

• Dispose of waste properly: Any residues or used containers must be discarded following chemical safety disposal procedures.

• Limit exposure time: Due to the compound’s potency, minimize open-air handling and promptly reseal storage containers after use.

Desoxypipradrol is widely used in neuroscience and pharmacology laboratories due to its strong and selective dopamine reuptake inhibition. Its long-lasting activity makes it particularly useful in studies requiring extended stimulant effects without the need for repeated dosing. Researchers utilize 2-DPMP in both in vivo and in vitro models to investigate dopaminergic function, stimulant-induced behaviors, and transporter binding kinetics.

• Investigation of dopamine transporter (DAT) mechanisms: 2-DPMP is a model compound for studying how dopamine reuptake inhibitors interact with DAT without triggering dopamine release.

• Behavioral pharmacology studies: It is commonly used in rodent experiments to assess hyperactivity, reward response, and locomotor sensitization due to its reliable stimulant effect.

• Comparison with other CNS stimulants: Researchers compare 2-DPMP’s potency, binding affinity, and effect profile against methylphenidate, amphetamines, and cocaine.

• Neurotoxicity screening: Due to its long duration, 2-DPMP helps determine whether prolonged DAT inhibition may cause dopaminergic neurotoxicity in experimental models.

• Binding assays and receptor profiling: In vitro binding studies help characterize the selectivity of 2-DPMP at various monoamine transporters.

• Metabolism and pharmacokinetics: Studies examine how 2-DPMP is absorbed, distributed, and metabolized in animal models, offering insights into how structural analogs behave in the body.

2-DPMP stands out among stimulant research chemicals due to its exceptional potency, long duration, and unique mechanism of action. Unlike amphetamines or cathinones, which act as releasing agents, 2-DPMP functions purely as a reuptake inhibitor, making it more predictable in controlled research settings. Its ability to bind strongly to DAT without significant interaction with serotonin or norepinephrine systems also contributes to its specificity.

• Extraordinarily high potency: Even sub-milligram doses can produce significant behavioral changes in laboratory models, reducing the quantity needed for studies.

• Extended stimulation duration: Effects last up to 24 hours or longer, allowing for long-term observation without re-dosing.

• Minimal serotonergic activity: Unlike many stimulants, 2-DPMP has very limited action at the serotonin transporter (SERT), reducing serotonin-related side effects in models.

• Non-releasing action: It blocks dopamine reuptake rather than reversing transporter flow like methamphetamine or mephedrone.

• Low risk of acute tolerance: While long-term studies are ongoing, 2-DPMP does not rapidly lose efficacy in short-term dosing models.

• More stable in storage: Its resistance to oxidation and degradation makes it easier to store compared to some unstable amphetamines or phenethylamines.

Mixing 2-DPMP with other research chemicals is highly discouraged unless the study is specifically designed to investigate compound interactions. Due to its potent dopaminergic effect, co-administration with other stimulants or neurotransmitter modulators can create unpredictable or hazardous outcomes. It’s best used in isolation unless interaction studies are being conducted under controlled and well-documented conditions.

• Potential for enhanced stimulant toxicity: When combined with other DRIs, releasing agents, or monoamine oxidase inhibitors, overstimulation and neurotoxicity risks increase significantly.

• Can distort pharmacological data: Mixing may result in non-linear or misleading behavioral outcomes, making it difficult to draw valid conclusions.

• Confounding variables in behavioral studies: Interaction effects may overshadow the individual action of each compound, complicating interpretation.

• Greater strain on regulatory approval: Multi-compound research requires stricter documentation and oversight, particularly in toxicology or neuroscience.

• Some combinations may increase cardiovascular risks in vivo: In animal models, stimulant-stimulant interactions often lead to heart rate spikes, tremors, or seizure risk.

• Interaction studies require lower dosing strategies: If co-administration is necessary, it must be approached cautiously using titrated microdoses with advanced monitoring.

Proper storage of Desoxypipradrol is essential to preserve its potency and prevent degradation. Its crystalline powder form is relatively stable under ambient conditions, but optimal storage protocols help ensure long-term integrity. Researchers should always store this compound in accordance with standard chemical safety practices.

• Keep in a cool, dry place: Storage temperatures between 2°C and 8°C are ideal to maintain compound stability and prevent clumping or moisture absorption.

• Avoid exposure to light and heat: 2-DPMP is sensitive to UV light and elevated temperatures, which may cause chemical degradation or loss of potency over time.

• Use airtight containers: Glass vials with tight seals prevent contamination from moisture or airborne particles that may compromise purity.

• Label storage clearly: Include compound name, batch number, concentration, and hazard classification to avoid misidentification or improper use.

• Keep away from acids or oxidizers: Store separately from reactive substances that could chemically alter the compound.

• Track shelf life for long-term use: Although stable for over two years, record storage dates and monitor for any visual changes or discoloration over time.

While both 2-DPMP and methylphenidate act as dopamine reuptake inhibitors, their pharmacological profiles, potencies, and durations differ significantly. Methylphenidate is a clinically approved ADHD medication with moderate potency and short duration, whereas Desoxypipradrol is a much more potent and longer-lasting compound used only in research settings. Their structural and functional differences provide distinct applications in neuropharmacology studies.

• Potency: 2-DPMP is many times more potent than methylphenidate, with active doses often measured in micrograms rather than milligrams.

• Duration: Methylphenidate typically lasts 4 to 6 hours, while 2-DPMP may remain active for 12 to 24 hours or longer in experimental models.

• Legality and use: Methylphenidate is a Schedule II controlled substance used therapeutically, while 2-DPMP is sold strictly for non-human research purposes.

• Structural differences: Methylphenidate is a phenethylamine derivative, while 2-DPMP is built around a piperidine core, affecting how each interacts with the dopamine transporter.

• Tolerance profile: Methylphenidate can lead to rapid tolerance with repeated use, while 2-DPMP’s tolerance buildup is slower but requires careful monitoring due to accumulation risks.

• Selectivity: Methylphenidate shows some norepinephrine transporter affinity, whereas 2-DPMP is more dopamine-selective at standard research concentrations.

Desoxypipradrol (2-DPMP) is most commonly supplied in its raw powdered form, suitable for accurate dosing and flexible application in research settings. Its chemical stability and low dose requirements make the powder format practical and preferred among laboratories for both in vivo and in vitro studies.

• White crystalline powder: 2-DPMP usually appears as a fine, white to off-white powder with a crystalline texture, indicating high purity and proper synthesis.

• Packaged in secure containers: To maintain integrity and safety, it is typically sealed in aluminum foil bags or amber glass vials to protect from light, moisture, and contamination.

• Highly concentrated material: Given the compound’s potency, it is not diluted or blended with excipients—what you receive is 100% active chemical content, ideal for micro-dosing research.

• Suitable for precise weighing: The powder format allows for accurate microgram to milligram measurements using laboratory-grade scales, which is essential for low-dose research compounds.

• Can be dissolved for liquid experiments: It may be reconstituted in suitable solvents like ethanol, DMSO, or dilute acids for liquid-based assays or receptor binding studies.

• Clearly labeled with hazard markings: Responsible suppliers include storage instructions, batch IDs, and safety notices on the packaging to support proper laboratory use.

Desoxypipradrol is versatile in research and may be used in both in vivo (live animal) and in vitro (cellular or molecular) experimental setups. Its long-lasting activity, selective dopamine reuptake inhibition, and structural stability make it ideal for a variety of controlled laboratory studies.

• Common in rodent behavior models: In vivo studies often involve administering small, controlled doses to observe stimulant-induced behavioral changes like locomotion, reward seeking, or sleep disruption.

• Useful for dopamine transporter assays: In vitro studies utilize 2-DPMP to assess dopamine transporter function, binding affinity, and cellular uptake mechanisms.

• Controlled dosing is critical in vivo: Due to its high potency, in vivo dosing must be carefully calculated to prevent overstimulation or toxicity in research subjects.

• Limited diffusion in cell cultures: While effective in vitro, lipophilic compounds like 2-DPMP may require solvents or surfactants to ensure even distribution in aqueous media.

• Helps explore neuroadaptation effects: In vivo models may study long-term changes in behavior or receptor regulation following chronic exposure to potent DAT inhibitors like 2-DPMP.

• Supports transporter selectivity studies: In vitro use helps distinguish between dopamine, serotonin, and norepinephrine transporter activity, especially when comparing it to other reuptake inhibitors.

The solubility of 2-DPMP depends on the intended application and the solvent’s polarity. As a moderately lipophilic compound, 2-DPMP dissolves well in organic solvents and requires special handling when preparing aqueous solutions. Using the appropriate solvent ensures accurate dosing and experimental reproducibility.

• Ethanol: Commonly used for dissolution in pharmacological research; ensures quick and stable solubilization.

• Methanol and DMSO: Offer excellent solubility and are frequently used for stock solutions in cellular and receptor studies.

• Dilute hydrochloric acid: Can be used to create water-soluble salt forms of 2-DPMP, making it more manageable for in vitro applications involving aqueous media.

• Limited water solubility: In its freebase form, 2-DPMP is poorly soluble in water, so it is typically used with a co-solvent or converted into a salt.

• Acetonitrile: Occasionally used in high-performance liquid chromatography (HPLC) for compound detection and purity analysis.

• Always use solvent-grade chemicals: Solvents should be pure, fresh, and compatible with your intended assay or model to avoid impurities or reaction byproducts.

2-DPMP is a highly active central nervous system stimulant, and improper handling can pose significant hazards in a laboratory setting. Its potency, long duration, and ability to penetrate the blood-brain barrier make it especially risky for accidental exposure, requiring thorough safety protocols.

• Risk of overstimulation: Even small accidental exposure could lead to symptoms like agitation, rapid heart rate, and insomnia, as observed in animal toxicology studies.

• Not intended for human use: 2-DPMP has no clinical approvals and must never be tested on humans; exposure may result in unpredictable physiological responses.

• Powder is easily airborne: Fine particles can become suspended in air and pose inhalation hazards, particularly in non-ventilated spaces.

• Can cause contamination: If spilled, it may contaminate work surfaces or equipment, leading to unintended exposure or data integrity issues.

• Long biological half-life increases risk of accumulation: Repeated exposure or poor handling may lead to buildup in lab environments or within animal models.

• Requires certified disposal protocols: Waste materials, including contaminated gloves, vials, and pipette tips, must be disposed of as hazardous lab waste.

The molecular structure of Desoxypipradrol provides insight into its pharmacological behavior and potency. It features a rigid piperidine backbone with two phenyl groups, contributing to high binding affinity for the dopamine transporter and exceptional lipid solubility. These structural characteristics underpin its long duration and selectivity.

• Piperidine core ensures transporter compatibility: This backbone is commonly seen in compounds that interact strongly with monoamine transporters, particularly DAT.

• Diphenyl substitution enhances potency: The two phenyl groups create a lipophilic environment that supports high-affinity binding to the hydrophobic regions of DAT.

• Minimal polar functional groups: The absence of hydroxyl or amine substitutions reduces renal clearance and increases CNS residence time.

• High lipophilicity aids brain penetration: Lipid solubility allows rapid and efficient crossing of the blood-brain barrier, resulting in fast onset and sustained central action.

• Structural rigidity contributes to metabolic stability: The non-flexible framework resists enzymatic breakdown, prolonging activity and reducing metabolic clearance.

• Non-amphetamine structure: Its distinct non-phenethylamine design means it behaves differently than common stimulants like methamphetamine or cathinone analogs, especially in terms of abuse liability and neurotransmitter release.

Proper labeling of Desoxypipradrol is a critical part of laboratory safety and regulatory compliance. Accurate labels help prevent accidental misuse, ensure traceability, and provide essential information about hazards and intended use. In research environments, every container of 2-DPMP must be clearly marked to reflect its contents and status as a restricted-use chemical.

• Label as “For Research Use Only”: This designation must be prominently displayed to ensure no one mistakes it for a consumable or approved medication.

• Include chemical name and synonyms: Use both the full IUPAC name (2-diphenylmethylpiperidine) and its common name (Desoxypipradrol or 2-DPMP) for clarity.

• State purity and concentration: If applicable, include the batch-specific purity percentage (e.g., ≥98.5%) to help researchers with dosing and planning.

• Add hazard warnings: Indicate stimulant properties, potential for toxicity, and personal protection requirements (e.g., wear gloves, avoid inhalation).

• Batch number and supplier information: Traceability is essential for quality control and potential recall situations.

• Storage instructions: “Keep in a cool, dry place; protect from light” should be included to maintain compound stability.

• Date of receipt and expiration: Helps lab personnel rotate stock and avoid using expired or degraded chemicals.